- Home
- NRXS vs SEED Comparison
NRXS vs SEED Comparison
Compare NRXS & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- SEED
- Stock Information
- Founded
- NRXS 2011
- SEED 1997
- Country
- NRXS United States
- SEED China
- Employees
- NRXS N/A
- SEED N/A
- Industry
- NRXS
- SEED Farming/Seeds/Milling
- Sector
- NRXS
- SEED Consumer Staples
- Exchange
- NRXS Nasdaq
- SEED Nasdaq
- Market Cap
- NRXS 13.0M
- SEED 10.7M
- IPO Year
- NRXS 2023
- SEED N/A
- Fundamental
- Price
- NRXS $2.27
- SEED $1.22
- Analyst Decision
- NRXS
- SEED
- Analyst Count
- NRXS 0
- SEED 0
- Target Price
- NRXS N/A
- SEED N/A
- AVG Volume (30 Days)
- NRXS 29.8K
- SEED 25.6K
- Earning Date
- NRXS 05-12-2025
- SEED 05-20-2025
- Dividend Yield
- NRXS N/A
- SEED N/A
- EPS Growth
- NRXS N/A
- SEED N/A
- EPS
- NRXS N/A
- SEED 0.46
- Revenue
- NRXS $2,934,945.00
- SEED $16,163,803.00
- Revenue This Year
- NRXS $138,883.78
- SEED N/A
- Revenue Next Year
- NRXS $118.59
- SEED N/A
- P/E Ratio
- NRXS N/A
- SEED $2.71
- Revenue Growth
- NRXS 27.52
- SEED 21.51
- 52 Week Low
- NRXS $1.33
- SEED $1.10
- 52 Week High
- NRXS $3.78
- SEED $6.38
- Technical
- Relative Strength Index (RSI)
- NRXS 54.13
- SEED 39.03
- Support Level
- NRXS $1.94
- SEED $1.10
- Resistance Level
- NRXS $2.42
- SEED $1.50
- Average True Range (ATR)
- NRXS 0.26
- SEED 0.08
- MACD
- NRXS 0.01
- SEED 0.02
- Stochastic Oscillator
- NRXS 60.45
- SEED 31.08
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.